Cancer Molecular Therapeutics Research Association
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 130,435 | 133,305 | −2,870 | 4.9 | — |
| 2012 | 82,019 | 72,370 | 9,649 | 10.7 | — |
| 2013 | 102,458 | 88,696 | 13,762 | 10.6 | — |
| 2014 | 97,706 | 121,175 | −23,469 | 5.4 | — |
| 2015 | 98,147 | 81,186 | 16,961 | 10.6 | — |
| 2016 | 78,552 | 62,997 | 15,555 | 16.6 | — |
| 2017 | 57,936 | 77,241 | −19,305 | 10.5 | — |
| 2018 | 93,110 | 122,755 | −29,645 | 3.7 | — |
| 2019 | 59,211 | 37,257 | 21,954 | 19.4 | — |
| 2020 | 0 | 3,012 | −3,012 | 227.7 | — |
| 2021 | 14,595 | 3,012 | 11,583 | 273.8 | — |
In its most recent public year (2021), this organization brought in $11,583 more than it spent. Its reserves stood at about 273.8 months of spending, up from 4.9 in 2011.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2021. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Cancer Molecular Therapeutics Research Association's IRS filings as a feed — one entry per filing year, through 2021. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works